These limitations emphasize the need for future research to address these issues, such as performing BCR repertoire analysis, and validating the molecular characteristics and function of cancer stem cell-like B cells by in vivo and in vitro experiments, to enhance the robustness and generalizability of our findings. The gene discussed is BCR; the disease is cancer.